AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
South America Immunodiagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)
... Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others) The South America immunodiagnostics market is expected to grow from US$ 887.91 million in 2022 to US$ 1,399.57 million by 2028; ... Read More
-
Point of Care Molecular Diagnostics Market Size by Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhoea, Chlamydia, Hepatitis C, Hepatitis B, COVID-19}, Oncology, Hematology), By End-use (Hospitals, Clinics, Diagnostic Centers), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Oncology, Hematology), By End-use (Hospitals, Clinics, Diagnostic Centers), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 Point of Care Molecular Diagnostics Market is anticipated to register growth through ... Read More
-
Sexually Transmitted Disease (STD) Testing Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Disease (Chlamydia, Syphilis, Gonorrhea, Hyper Simplex Virus Human Immunodeficiency Virus, Chancroid); By Location (Laboratory, Point of Care (PoC)); By Device (Laboratory Devices, Point of Care (PoC) Devices); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Care (PoC)); By Device (Laboratory Devices, Point of Care (PoC) Devices); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Global Sexually Transmitted Disease Testing Market Size Expands to Cross USD ... Read More
-
HIV/AIDS Diagnostics Market (Product: Kits and Reagents and Instruments; and Test Type: Nucleic Acid Tests, Rapid Tests, ELISA, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Scope of Report TMR’s report on the global HIV/AIDS diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the ... Read More
-
Human Immunodeficiency Virus (HIV) Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033
... Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on HIV Tests market ... Read More
-
Gonorrhea - Drug Pipeline Landscape, 2023
... cervix. Symptoms of Gonorrhea infection in men include painful urination, pain or swelling in one testicle and in women include increased vaginal discharge, painful urination, vaginal bleeding between periods and abdominal or pelvic pain. Diagnosis ... Read More
-
The Market for In Vitro Diagnostic (IVD) Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and Other Nations)
... on the market for reagents and instruments in the most important countries of the region. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis; the countries of ... Read More
-
Influenza Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type, By Indication, By Route Of Administration, By Age Group, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
... Growth & Trends The global influenza vaccine market size is expected to reach USD 12.37 billion by 2030 and is set to expand at 6.83% CAGR from 2023 to 2030, according to a new report ... Read More
-
U.S. Women Health Laboratory Testing Market - A Region-Wise Analysis: Focus on U.S. Women Health Laboratory Testing Market - Analysis and Forecast, 2022-2030
... laboratory testing market was valued at $72.8 billion in 2021 and is anticipated to reach $106.8 billion by 2030, witnessing a CAGR of 4.30% during the forecast period 2022-2030. The market is driven by factors ... Read More
-
Infectious Disease Diagnostics Market Report 2022-2032
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Growing Prevalence of Infectious Diseases, And Shift in ... Read More
-
Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) - Forecast to 2027
... market is estimated to register a CAGR of 7.1% to reach USD 379 million by 2027 from USD 269 million in 2022. The growing prevalence of cancer and HIV/ AIDS, growing research activities which adopt ... Read More
-
Global HIV/HBV/HCV Test Kits Market - 2022-2029
... a CAGR of 6.8 % during the forecast period (2022-2029). HIV/HBV/HCV test is a test of qualitative detection and differentiation of hepatitis B surface antigen (HBsAg) and antibodies to HIV-1, HIV-2, Treponema pallidum (Tp), and ... Read More
-
The World Market for Molecular Diagnostics Tests, 11th Edition
... NIPT, Other) Blood Banking Molecular Diagnostics Markets Transplantation Molecular Diagnostic Markets Regional Molecular Diagnostics Markets (North America, Europe, Asia, Global) This report is published as the industry experienced accelerated installed bases and new product introductions. ... Read More
-
Antiviral Drugs Market Report 2022-2032
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Introduction of Blockbuster Drugs to Boost Market Growth Antiviral medicines ... Read More
-
HIV and HBV Therapies Market Report 2022-2032
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Factors Such as Rising Prevalence of ... Read More
-
Africa HIV Treatment Drugs Market 2023-2027
... during the forecast period. Our report on the HIV treatment drugs market in Africa provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 ... Read More
-
Global Sexually Transmitted Diseases (STD) Testing Market Size study & Forecast, by Disease Type (Chlamydia, Gonorrhea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), and Other Diseases) and Location of Testing (Laboratory Testing, and Point-of-care (POC) Testing) and Regional Analysis, 2022-2029
... Testing, and Point-of-care (POC) Testing) and Regional Analysis, 2022-2029 Global Sexually Transmitted Diseases (STD) Testing Market is valued approximately USD 96.06 billion in 2021 and is anticipated to grow with a healthy growth rate of ... Read More
-
Genital Herpes - Epidemiology Forecast - 2032
... EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China. Geography Covered The United States EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan China Study Period: 2019-2032 Genital Herpes understanding The ... Read More
-
Genital Herpes - Market Insight, Epidemiology And Market Forecast - 2032
... the Genital Herpes trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), Japan and China. The Genital Herpes market report provides emerging drugs, Genital Herpes market share of the individual cancer ... Read More
-
Chlamydia - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Chlamydia Understanding ... Read More
-
Genital Herpes - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Sexually Transmitted Diseases Diagnostics Market Insights, Competitive Landscape and, Market Forecast - 2027
... AND OTHERS), BY TESTING (LABORATORY DEVICES [PCR, LTERAL FLOW READERS IMMUNOCHROMATOGRAPHIC ASSAY, FLOW CYTOMETERS, ABSORBANCE MICROPLATE READERS ENZYME LINKED IMMUNOSORBENT ASSAY, AND OTHERS] AND POINT OF CARE DEVICES [PHONE CHIPS, PORTABLE/BENCH, AND DIAGNOSTIC KITS]), BY ... Read More
-
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Kaposi Sarcoma (Infectious Disease) pipeline landscape. Kaposi's sarcoma is a cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and ... Read More
-
Cell Counting Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... significant impact on the adoption of cell counting products and consumables. The pandemic witnessed increased adoption of cell counting devices, as osteopenia and lymphopenia are the potential indicators of COVID-19. The study published in BMC ... Read More
-
Infectious Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... USD 50,345.74 million. The infectious disease diagositcs market is expected to register a CAGR of 3.79% over the forecast period (2022-2027). The market for infectious illness diagnostics has been considerably affected by the COVID-19 epidemic. ... Read More
Research Assistance
